Leptographium bhutanense sp. nov., associated with the root collar weevil Hylobitelus chenkupdorjii on Pinus wallichiana in Bhutan

Leptographium spp. are commonly associated with bark beetles and weevils (Coleoptera: Curculionidae), and some are important tree pathogens. In a recent survey of diseases and insect pests of conifer trees in Bhutan, the root collar weevil, Hylobitelus chenkupdorjii was found girdling young Himalayan blue pine (Pinus wallichiana) trees in Central Bhutan. Intensive wood staining and a Leptographium sp. were associated with damage by this insect. The fungus was also isolated from individuals of H. chenkupdorjii. It was tentatively identified based on morphology and then compared with other Leptographium spp. using DNA sequences for three gene regions. Morphological characteristics showed that the Leptographium sp. from H. chenkupdorjii is similar to, but distinct from L. procerum and L. profanum. DNA sequence comparisons revealed that the isolates from Bhutan resided in a distinct well-supported clade and confirmed that they represent an undescribed taxon for which the name Leptographium bhutanense sp. nov. is provided

Review of clinical brachytherapy uncertainties: Analysis guidelines of GEC-ESTRO and the AAPM

Background and purpose A substantial reduction of uncertainties in clinical brachytherapy should result in improved outcome in terms of increased local control and reduced side effects. Types of uncertainties have to be identified, grouped, and quantified. Methods A detailed literature review was performed to identify uncertainty components and their relative importance to the combined overall uncertainty. Results Very few components (e.g., source strength and afterloader timer) are independent of clinical disease site and location of administered dose. While the influence of medium on dose calculation can be substantial for low energy sources or non-deeply seated implants, the influence of medium is of minor importance for high-energy sources in the pelvic region the level of uncertainties due to target, organ, applicator, and/or source movement in relation to the geometry assumed for treatment planning is highly dependent on fractionation and the level of image guided adaptive treatment. Most studies to date report the results in a manner that allows no direct reproduction and further comparison with other studies. Often, no distinction is made between variations, uncertainties, and errors or mistakes the literature review facilitated the drafting of recommendations for uniform uncertainty reporting in clinical BT, which are also provided the recommended comprehensive uncertainty investigations are key to obtain a general impression of uncertainties, and may help to identify elements of the brachytherapy treatment process that need improvement in terms of diminishing their dosimetric uncertainties. It is recommended to present data on the analyzed parameters (distance shifts, volume changes, source or applicator position, etc.), and also their influence on absorbed dose for clinically-relevant dose parameters (e.g., target parameters such as D90 or OAR doses). Publications on brachytherapy should include a statement of total dose uncertainty for the entire treatment course, taking into account the fractionation schedule and level of image guidance for adaptation. Conclusions This report on brachytherapy clinical uncertainties represents a working project developed by the Brachytherapy Physics Quality Assurances System (BRAPHYQS) subcommittee to the Physics Committee within GEC-ESTRO. Further, this report has been reviewed and approved by the American Association of Physicists in Medicine. © 2013 Elsevier Ireland Ltd. All rights reserved

Electrochemical removal of bromate from drinking water

The electrochemical removal of bromate on a tin cathode has been studied by both electrochemical techniques, such as cyclic voltammetry and chronoamperometry, as well as by steady-state electrolytic experiments. The reduction of bromate in 2M NaCl takes place efficiently at potentials more negative than -1.4V vs. Ag/AgCl and the rate of the reduction displays a maximum at about -1.8 V, then decreases and consequently it increases again as the potential becomes more negative than -1.9 V. The % removal efficiency of bromate displays a maximum (75.6%) at -1.8 V, while the % selectivity of bromide displays a minimum (70.3%) at the same potential

Evidence for associations between the purinergic receptor P2X₇ (P2RX7) and toxoplasmosis

Congenital Toxoplasma gondii infection can result in intracranial calcification, hydrocephalus and retinochoroiditis. Acquired infection is commonly associated with ocular disease. Pathology is characterized by strong proinflammatory responses. Ligation of ATP by purinergic receptor P2X7, encoded by P2RX7, stimulates proinflammatory cytokines and can lead directly to killing of intracellular pathogens. To determine whether P2X7 has a role in susceptibility to congenital toxoplasmosis, we examined polymorphisms at P2RX7 in 149 child/parent trios from North America. We found association (FBAT Z-scores ±2.429; P=0.015) between the derived C(+)G(−) allele (f=0.68; OR=2.06; 95% CI: 1.14–3.75) at single-nucleotide polymorphism (SNP) rs1718119 (1068T>C; Thr-348-Ala), and a second synonymous variant rs1621388 in linkage disequilibrium with it, and clinical signs of disease per se. Analysis of clinical subgroups showed no association with hydrocephalus, with effect sizes for associations with retinal disease and brain calcifications enhanced (OR=3.0–4.25; 0.004<P<0.009) when hydrocephalus was removed from the analysis. Association with toxoplasmic retinochoroiditis was replicated (FBAT Z-scores ±3.089; P=0.002) in a small family-based study (60 families; 68 affected offspring) of acquired infection in Brazil, where the ancestral T(+) allele (f=0.296) at SNP rs1718119 was strongly protective (OR=0.27; 95% CI: 0.09–0.80)